Literature DB >> 17279615

The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.

Sarah J Siegel1, Jan Bieschke, Evan T Powers, Jeffery W Kelly.   

Abstract

4-Hydroxynonenal (4-HNE), formed as a consequence of oxidative stress, exists at increased concentrations in Alzheimer's disease (AD) patients and is found in amyloid beta peptide (Abeta) plaques associated with AD. Although it remains an open question as to whether oxidative stress is a causative factor or a consequence of AD, we show here that 4-HNE, putatively resulting from the peroxidation of lipids, covalently modifies Abeta, triggering its aggregation. These Abeta modifications result from 1,4 conjugate addition and/or Schiff base formation, they occur at multiple locations on a single Abeta peptide, and they result in covalent cross-linking of Abeta peptides. The consequence of these reactions is that 4-HNE accelerates the formation of Abeta protofibrils while inhibiting the production of straight, mature fibrils. Recent studies implicating Abeta oligomers and protofibrils in the neurotoxic process that ultimately leads to AD suggest that the Abeta aggregates induced by 4-HNE may be important in the pathogenesis of AD. These results provide further incentive to understand the role of oxidative stress and small-molecule Abeta modifications in sporadic AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279615      PMCID: PMC2530822          DOI: 10.1021/bi061853s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde.

Authors:  L T McGrath; B M McGleenon; S Brennan; D McColl; S McILroy; A P Passmore
Journal:  QJM       Date:  2001-09

3.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

4.  Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.

Authors:  P D Mehta; T Pirttila; B A Patrick; M Barshatzky; S P Mehta
Journal:  Neurosci Lett       Date:  2001-05-18       Impact factor: 3.046

5.  4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release.

Authors:  C Ji; V Amarnath; J A Pietenpol; L J Marnett
Journal:  Chem Res Toxicol       Date:  2001-08       Impact factor: 3.739

Review 6.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.

Authors:  D Allan Butterfield
Journal:  Free Radic Res       Date:  2002-12

7.  Characterisation of adducts of the lipid peroxidation product 4-hydroxy-2-nonenal and amyloid beta-peptides by liquid chromatography/electrospray ionisation mass spectrometry.

Authors:  F Magni; C Galbusera; L Tremolada; C Ferrarese; M Galli Kienle
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 9.  Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins.

Authors:  Marina Carini; Giancarlo Aldini; Roberto Maffei Facino
Journal:  Mass Spectrom Rev       Date:  2004 Jul-Aug       Impact factor: 10.946

10.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

View more
  57 in total

Review 1.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 2.  Transdermal delivery of treatment for Alzheimer's disease: development, clinical performance and future prospects.

Authors:  Agnes L F Chan; Yie W Chien; Shun Jin Lin
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Membrane peroxidation and methemoglobin formation are both necessary for band 3 clustering: mechanistic insights into human erythrocyte senescence.

Authors:  Nobuto Arashiki; Naoki Kimata; Sumie Manno; Narla Mohandas; Yuichi Takakuwa
Journal:  Biochemistry       Date:  2013-08-16       Impact factor: 3.162

Review 4.  Exploring the biology of lipid peroxidation-derived protein carbonylation.

Authors:  Kristofer S Fritz; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2011-08-18       Impact factor: 3.739

5.  Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity.

Authors:  Kenji Usui; John D Hulleman; Johan F Paulsson; Sarah J Siegel; Evan T Powers; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

Review 6.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 7.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen'.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

Review 8.  Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases.

Authors:  Tetsumori Yamashima; Tsuguhito Ota; Eishiro Mizukoshi; Hiroyuki Nakamura; Yasuhiko Yamamoto; Mitsuru Kikuchi; Tatsuya Yamashita; Shuichi Kaneko
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 9.  Mitochondrial damage & lipid signaling in traumatic brain injury.

Authors:  Andrew M Lamade; Tamil S Anthonymuthu; Zachary E Hier; Yuan Gao; Valerian E Kagan; Hülya Bayır
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

10.  Lower serum uric acid levels in cerebral amyloid angiopathy: a pilot study.

Authors:  Qi Hu; Anding Liu; Mengyang Huang; Luo Cheng; Huicong Kang; Feng Xu; Xiaoyan Liu; Lifei Lian; Qiming Liang; Hong Jiang; Cuntai Zhang; Suiqiang Zhu
Journal:  Neurol Sci       Date:  2014-01-25       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.